CIK 0000093314
- Non-accelerated filer
- Smaller reporting company
VOLITIONRX LTD
Sign in to watch- Ticker
- VNRX
- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911949078
- Phone
- +1 512-774-8930
- Business address
- 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-28 | Butera Salvatore Thomas CEO - Volition Veterinary | Shares withheld for taxes | −5,230 | $0.61 | $3K | 332,285 |
| 2025-09-28 | Micallef Jacob Vincent Chief Scientific Officer | Shares withheld for taxes | −5,568 | $0.61 | $3K | 398,939 |
| 2025-09-28 | Batchelor Ann-Louise Group Chief Marketing Officer | Shares withheld for taxes | −5,604 | $0.61 | $3K | 154,282 |
| 2025-09-28 | Michel Gaetan Chief Operating Officer | Shares withheld for taxes | −11,362 | $0.61 | $7K | 369,079 |
| 2025-09-28 | Forterre Gael Chief Commercial Officer | Shares withheld for taxes | −5,503 | $0.61 | $3K | 160,924 |
| 2025-09-12 | Reynolds Cameron John President and CEO | Purchase | +15,000 | $0.66 | $10K | 2,624,847 |
| 2025-08-15 | Hughes Terig Chief Financial Officer | Grant or award | +26,143 | 533,770 | ||
| 2025-08-15 | Batchelor Ann-Louise Group Chief Marketing Officer | Grant or award | +27,400 | 159,886 | ||
| 2025-08-15 | Rootsaert Rodney Gerard Secretary | Grant or award | +15,223 | 149,233 | ||
| 2025-08-15 | Butera Salvatore Thomas CEO - Volition Veterinary | Grant or award | +33,991 | 337,515 | ||
| 2025-08-15 | Retter Andrew Chief Medical Officer | Grant or award | +19,524 | 151,156 | ||
| 2025-08-15 | Plummer Nicholas GC - Volition Diagnostics | Grant or award | +24,031 | 207,877 | ||
| 2025-08-15 | Rubin Ethel Director | Grant or award | +17,424 | 62,948 | ||
| 2025-08-15 | Nguyen Kim Director | Grant or award | +17,424 | 115,816 | ||
| 2025-08-15 | Kway Jasmine CEO - Singapore Volition | Grant or award | +12,507 | 203,614 | ||
| 2025-08-15 | Forterre Gael Chief Commercial Officer | Grant or award | +9,727 | 166,427 | ||
| 2025-08-05 | Innes Guy Archibald Director | Purchase | +78,125 | $0.64 | $50K | 966,814 |
| 2025-08-05 | Reynolds Cameron John President and CEO | Purchase | +78,125 | $0.64 | $50K | 2,609,847 |
| 2025-08-01 | Butera Salvatore Thomas CEO - Volition Veterinary | Shares withheld for taxes | −6,393 | $0.64 | $4K | 303,524 |
| 2025-08-01 | Retter Andrew Chief Medical Officer | Shares withheld for taxes | −6,142 | $0.64 | $4K | 131,632 |
Page 4 of 6 · 107 trades